Sensei Biotherapeutics Inc expected to post a loss of 37 cents a share - Earnings Preview

Faeth Therapeutics,

04/11/2022 17:41

* Sensei Biotherapeutics Inc  SNSE.OQ   SNSE.O  is expected
to show no change in quarterly revenue when it reports 
results on November 7 (estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Sensei
Biotherapeutics
Inc is for a loss of 37 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Sensei
Biotherapeutics Inc is $5​, above​ its last closing price
of $1.34. ​​​

This summary was machine generated November 4 at 17:41 GMT.  All
figures in US dollars  unless otherwise stated